Adama Ibrahim, EMBA
Associate Director of Global Clinical Operations at Biogen & Founder Founder of EMQT
A 2018 Sunday Times Rising Stars in Healthcare award winning operational strategy expert, consulting expert, blockchain advocate, technology enabled clinical trials (direct to patients/Virtual Trials) and patient engagement thought leader with over 17 years in the NHS on commission by the DOH and in Industry (Hoffman La-Roche, Amgen, ALMAC, ICON and Biogen). An R&D transformation change champion and DIA Patient Engagement Voluntary Community Leadership. Far-reaching and varied knowledge across a broad range of Phase I, II, III and IV trials including Immunology, Neurology, IBD, Rare Disease and Gene Therapy. Experience across creation and execution of successful strategies for trials protocols and CRO oversight, patient and site feasibility, technologies such as eCOA and IVRS, optimal drug packaging and administration concepts, mapping the patient journey, planning and executing effective global site and patient engagement campaigns using direct to patient methods, leading and coaching remote and complex global teams. Founder of a non-profit called Emerging Markets Quality Trials (EMQT) that aims to advance technology enabled clinical trials using AI and blockchain in emerging markets. I am a professional international Speaker and Trainer and also an Allbrights Academy Ambassador and mentor women in Berkshire.